糖尿病

订阅

MedSci主页 / 所有栏目 / 糖尿病

Diabetes Care：中青年糖尿病患者接种乙肝疫苗具有适度成本效益

2012-09-05 高晓方 医学论坛网

糖尿病乙肝疫苗成本效益中青年
关注

　　美国学者的一项研究表明，20～59岁糖尿病患者接种乙肝疫苗具有适度成本效益，老年人群接种则不具备成本效益。论文于2012年8月28日在线发表于《糖尿病护理》（Diabetes Care）杂志。 　　研究者利用成本效益仿真模型对糖尿病患者（20～59岁）接种乙肝疫苗的成本效益进行分析；模拟受试者既往未接种疫苗或感染乙肝病毒。利用模型对急性和慢性乙肝病毒感染、并发症、质量调整生命年（Q

　　美国学者的一项研究表明，20～59岁糖尿病患者接种乙肝疫苗具有适度成本效益，老年人群接种则不具备成本效益。论文于2012年8月28日在线发表于《糖尿病护理》（Diabetes Care）杂志。

　　研究者利用成本效益仿真模型对糖尿病患者（20～59岁）接种乙肝疫苗的成本效益进行分析；模拟受试者既往未接种疫苗或感染乙肝病毒。利用模型对急性和慢性乙肝病毒感染、并发症、质量调整生命年（QALY）和增量成本效益比进行评估。

　　研究将接种528047例受试者，并预防4271例急性和256例慢性乙肝病毒感染。净医疗保健费用将增加9.14千万美元，QALY为1218；产生的成本效益比为75094美元/QALY。结果对年龄、折现率、糖尿病人群乙肝发病率和乙肝感染率最为敏感。成本效益比随接种年龄增加而升高。

　　链接：

Hoerger TJ, Schillie S, Wittenborn JS, Bradley CL, Zhou F, Byrd K, Murphy TV.Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes.Diabetes Care. 2012 Aug 28


    

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2013-03-04 ms5439512287675881

    #BET#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2013-04-30 木头人513

    #Diabetes#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2013-02-03 ms9608593228839890

    #DIA#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2012-09-07 zhaojie88

    #成本效益#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2012-09-07 xue8604

    #糖尿病患者#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1759194, encodeId=a4f51e5919456, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 04 18:07:00 CST 2013, time=2013-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901003, encodeId=294819010033e, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Apr 30 08:07:00 CST 2013, time=2013-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636566, encodeId=2b7c16365666f, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 03 23:07:00 CST 2013, time=2013-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1359828, encodeId=cf761359828f2, content=<a href='/topic/show?id=8efa5402320' target=_blank style='color:#2F92EE;'>#成本效益#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54023, encryptionId=8efa5402320, topicName=成本效益)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473666, encodeId=5ec314e366664, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596154, encodeId=ac9015961541e, content=<a href='/topic/show?id=6e342260237' target=_blank style='color:#2F92EE;'>#中青年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22602, encryptionId=6e342260237, topicName=中青年)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e72b18339957, createdName=xuyu, createdTime=Fri Sep 07 02:07:00 CST 2012, time=2012-09-07, status=1, ipAttribution=)]
    2012-09-07 xuyu

    #中青年#

    0

相关资讯

FASEB J：产妇摄入高胆碱食物或会减少婴儿高血压和糖尿病的风险

来自于美国康奈尔大学的研究显示，产妇在孕晚期增加胆碱摄入可能会减少婴儿今后发生与代谢和长期应激相关的高血压和糖尿病的风险。研究结果发布在最新一期的美国社团联合会杂志实验生物学上，文章指出，在鸡蛋等食物中含量很高的胆碱可以帮助婴儿对抗母亲怀孕期间的应激影响。以往的研究指出，如果在怀孕期间如果由于对于即将成为母亲这件事情产生较多的焦虑或者抑郁情绪导致接受较多的应激激素皮质醇的刺激，可能会导致其婴儿对于

[ESC2012] 工作场所健身更有效预防疾病

　　一项德国研究者进行的工作健身计划的初期数据提示，如果在工作场所而不是在医生诊所进行干预，预防策略可能会更有效。该计划始于2005年，最终减少了吸烟、改善了血压控制、降低了代谢综合征发病率，并改善了10年预期的心血管疾病危险。该研究结果在欧洲心脏病学会2012年会上报告。 　　研究者指出，工作场所更适于进行一级和二级预防，更年轻的患者，包括未测出高血压和胆固醇水平升高者，并不经常接受医生的一级

Diabetes Care:靶向HbA1c改善透析糖尿病患者死亡率

　　 　　 欧美学者的透析转归和实践特征研究（DOPPS）的最新结果表明，在伴有1型或2型糖尿病的透析患者中糖化血红蛋白（HbA1c）水平强烈预测患者死亡率。HbA1c在7%~7.9%区间之外时死亡率升高，因而，调整透析患者降糖治疗药物可作为改善转归的临床实践。论文于2012年8月21日在线发表于《糖尿病护理》（Diabetes Care）杂志。 　　 此项研究共纳入9201例伴有1型或2型糖

加快糖尿病教育管理向基层推进

　　“我国糖尿病患者已有9240万人，糖尿病前期患者有1.4亿人，糖尿病防治形势十分严峻。”在8月12日结束的中华医学会糖尿病学分会教育管理研讨会暨2012 国际糖尿病教育管理论坛上，中华医学会糖尿病学分会主任委员纪立农教授向与会者如此讲述，并强调应重视基层医疗机构中的糖尿病诊治。 　　与会专家呼吁，糖尿病教育管理工作要取得更大成效，必须将关口前移、重心下沉，向基层卫生机构和农村地区推

Diabetes Care：双激素仿生学内分泌胰腺实现优异的血糖控制

　　美国学者的一项研究表明，双激素仿生学内分泌胰腺可实现优异的血糖控制，并且低血糖发生率极低。论文于2012年8月24日在线发表于《糖尿病护理》（Diabetes Care）杂志。 　　此项研究共纳入6例无内源性胰岛素分泌的1型糖尿病患者。利用仿生学内分泌胰腺管理血糖，可通过胰岛素泵控制胰岛素和胰高血糖素的皮下释放。在各餐开始时注射膳食引发胰岛素。通过静脉血参照质量测定评估血糖控制。

Diabetes Care：减肥术降血糖和改善β细胞功能

　　欧洲学者的一项研究表明，Roux-en-Y胃旁路手术（RYGB）可降低血糖浓度和改善β细胞功能，并且术后胃肠道葡萄糖吸收低于对照者。论文于2012年8月24日在线发表于《糖尿病护理》（Diabetes Care）杂志。 　　此项研究共纳入6例非糖尿病性病态肥胖患者。通过与肥胖对照者和消瘦对照者对比，在RYGB手术之前（pre-OP）和（7±1）个月后（post-OP）评估手术对β细